SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-104607
Filing Date
2019-04-12
Accepted
2019-04-12 09:01:57
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A d626180ds3a.htm S-3/A 454318
2 EX-23.1 d626180dex231.htm EX-23.1 1955
3 EX-99.1 d626180dex991.htm EX-99.1 32788
4 EX-99.2 d626180dex992.htm EX-99.2 10841
5 EX-99.3 d626180dex993.htm EX-99.3 11178
6 EX-99.4 d626180dex994.htm EX-99.4 8496
7 EX-99.5 d626180dex995.htm EX-99.5 22791
8 EX-99.6 d626180dex996.htm EX-99.6 17993
9 EX-99.7 d626180dex997.htm EX-99.7 14359
10 GRAPHIC g626180g0305202043518.jpg GRAPHIC 3284
  Complete submission text file 0001193125-19-104607.txt   580524
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-230085 | Film No.: 19745313
SIC: 2834 Pharmaceutical Preparations